BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17619328)

  • 1. [New definition of the metabolic syndrome--where does the disease begin?].
    Hauner H
    MMW Fortschr Med; 2006 Dec; 148(49-50):42-4. PubMed ID: 17619328
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric non-high-density lipoprotein cholesterol, the metabolic syndrome, and insulin resistance.
    Glueck CJ; Morrison JA
    J Pediatr; 2011 Feb; 158(2):179-81. PubMed ID: 21035129
    [No Abstract]   [Full Text] [Related]  

  • 3. Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?
    Yasuda T; Matsuhisa M; Fujiki N; Sakamoto F; Tsuji M; Fujisawa N; Kimura M; Ishibashi R; Kaneto H; Yamasaki Y; Watarai T; Imano E
    Endocr J; 2007 Dec; 54(5):695-702. PubMed ID: 17785919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
    Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
    Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?
    De Pergola G; Cortese F; Termine G; Meliota G; Carbonara R; Masiello M; Cortese AM; Silvestris F; Caccavo D; Ciccone MM
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):251-259. PubMed ID: 29437024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol.
    Gazi IF; Filippatos TD; Tsimihodimos V; Saougos VG; Liberopoulos EN; Mikhailidis DP; Tselepis AD; Elisaf M
    Lipids; 2006 Jul; 41(7):647-54. PubMed ID: 17069348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Parents History of Type 2 Diabetes with Metabolic Syndrome Component and Insulin Resistance in Non-Diabetic Young Adult Male.
    Aman AM; Rasyid H; Bakri S; Patellongi IJ
    Acta Med Indones; 2018 Oct; 50(4):309-313. PubMed ID: 30630995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults.
    Nascimento-Ferreira MV; Rendo-Urteaga T; Vilanova-Campelo RC; Carvalho HB; da Paz Oliveira G; Paes Landim MB; Torres-Leal FL
    Clin Nutr; 2017 Dec; 36(6):1693-1700. PubMed ID: 28081980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study.
    Birarra MK; Gelayee DA
    BMC Cardiovasc Disord; 2018 Jul; 18(1):149. PubMed ID: 30016936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
    Nimkuntod P; Tongdee P
    J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
    Pirri D; Fragiadaki M; Evans PC
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32816039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.
    Herder C; Kannenberg JM; Carstensen-Kirberg M; Huth C; Meisinger C; Koenig W; Peters A; Rathmann W; Roden M; Thorand B
    Cardiovasc Diabetol; 2017 Jan; 16(1):17. PubMed ID: 28143481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine is a marker for metabolic syndrome and atherosclerosis.
    Sreckovic B; Sreckovic VD; Soldatovic I; Colak E; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Mrdovic I
    Diabetes Metab Syndr; 2017; 11(3):179-182. PubMed ID: 27600468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Activity Patterns and Risk of Type 2 Diabetes and Metabolic Syndrome in Middle-Aged and Elderly Northern Chinese Adults.
    Wang Q; Zhang X; Fang L; Guan Q; Gao L; Li Q
    J Diabetes Res; 2018; 2018():7198274. PubMed ID: 30155489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the nature of metabolic syndrome components in children and what they can and cannot do to predict adult disease.
    Huang TT; Sun SS; Daniels SR
    J Pediatr; 2009 Sep; 155(3):e13-4. PubMed ID: 19732570
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV in elderly].
    Mück B; Trapana G; Jäger H
    MMW Fortschr Med; 2012 May; 154 Suppl 1():26-8. PubMed ID: 22916594
    [No Abstract]   [Full Text] [Related]  

  • 19. Smoking and the renal functional status of patients should be defined clearly in order to assess atherosclerosis and metabolic syndrome.
    Kurt Ö; Cakar M; Balta S; Sarlak H; Akhan M; Arslan E
    Intern Med; 2013; 52(20):2389. PubMed ID: 24126412
    [No Abstract]   [Full Text] [Related]  

  • 20. Spousal cardiometabolic risk factors and incidence of type 2 diabetes: a prospective analysis from the English Longitudinal Study of Ageing.
    Nielsen J; Hulman A; Witte DR
    Diabetologia; 2018 Jul; 61(7):1572-1580. PubMed ID: 29520580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.